Form 4 for CALX CALIX, INC
Accepted 2025-09-11 00:00:00 ET · period of report 2025-09-10 · accession 0001678385-25-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-11 | 2025-09-10+ | CALX | Weening Michael | Pres, CEO, Dir | M - OptEx | $7.84 | +176.0K | 24.1K | New | +$1.38M |
| DM | 2025-09-11 | 2025-09-10+ | CALX | Weening Michael | Pres, CEO, Dir | S - Sale+OE | $62.15 | -176.0K | 16.1K | -92% | -$10.94M |
| DM | 2025-09-11 | 2025-09-10+ | CALX | Weening Michael | Pres, CEO, Dir | M - OptEx | $0.00 | -176.0K | 292.0K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-10 | M | A | 150,000 | $7.84 | 166,117 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-10 | S | D | 150,000 | $62.00 | 16,117 | D | — | — | |
| 3 | Common | Common Stock | 2025-09-11 | S | D | 18,010 | $63.00 | 16,117 | D | — | — | |
| 4 | Common | Common Stock | 2025-09-10 | S | D | 7,990 | $63.00 | 16,117 | D | — | — | |
| 5 | Common | Common Stock | 2025-09-11 | M | A | 18,010 | $7.84 | 34,127 | D | — | — | |
| 6 | Common | Common Stock | 2025-09-10 | M | A | 7,990 | $7.84 | 24,107 | D | — | — | |
| 7 | Derivative | Stock Option (right to buy) | 2025-09-11 | M | D | 18,010 | $0.00 | 274,000 | D | $7.84 · — to 2029-11-27 | 18,010 Common Stock | (F1) 100% of the shares subject to the option were fully vested and exercisable on November 27, 2023. |
| 8 | Derivative | Stock Option (right to buy) | 2025-09-10 | M | D | 150,000 | $0.00 | 300,000 | D | $7.84 · — to 2029-11-27 | 150,000 Common Stock | (F1) 100% of the shares subject to the option were fully vested and exercisable on November 27, 2023. |
| 9 | Derivative | Stock Option (right to buy) | 2025-09-10 | M | D | 7,990 | $0.00 | 292,010 | D | $7.84 · — to 2029-11-27 | 7,990 Common Stock | (F1) 100% of the shares subject to the option were fully vested and exercisable on November 27, 2023. |